Announcement

Collapse
No announcement yet.

Eur J Case Rep Intern Med . A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • #1

    Eur J Case Rep Intern Med . A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination


    Eur J Case Rep Intern Med


    . 2021 Sep 14;8(9):002707.
    doi: 10.12890/2021_002797. eCollection 2021.
    A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination


    Yash Kripalani 1 , Vidyadhara Lakkappan 1 , Lipeeka Parulekar 2 , Anjum Shaikh 1 , Rakesh Singh 3 , Pradeep Vyas 1



    Affiliations

    Abstract

    Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. Their emergency administration in healthcare settings has been accompanied by numerous adverse effects. A case of Guillain-Barré syndrome following vaccination with Covishield is presented here to highlight this possible adverse condition.
    Learning points: Guillain-Barré Syndrome (GBS) is a very rare complication after vaccination against SARS-CoV-2.The key concepts related to the understanding, management and outcomes of patients with GBS are discussed.

    Keywords: AstraZeneca; ChAdOx1; Covishield; GBS; Guillain-Barré syndrome; coronavirus; pandemic; vaccine.

    Tags: None
Previous template Next
Working...
X